Skip to main content
OpenTrials

Clinical trial condition

Non-alcoholic Fatty Liver Disease

Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

1,138 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Non-alcoholic Fatty Liver Disease trial results

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NCT04048135

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations
  • 89bio Clinical Study Site Madison, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Tucson, Arizona, United States
  • 89bio Clinical Study Site Chula Vista, California, United States
View all 26 locations
View Trial Details

Related conditions